1. Sugenoya A, Shingu K, Kobayashi S, Masuda H, Takahashi S, Shimizu T, et al. Surgical strategies for differentiated carcinoma of the thyroid isthmus. Head Neck. 1993. 15:158–160.
2. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007. 246:375–384.
3. Noguchi M, Yamada H, Ohta N, Ishida T, Tajiri K, Fujii H, et al. Regional lymph node metastases in well-differentiated thyroid carcinoma. Int Surg. 1987. 72:100–103.
4. Noguchi M, Kinami S, Kinoshita K, Kitagawa H, Thomas M, Miyazaki I, et al. Risk of bilateral cervical lymph node metastases in papillary thyroid cancer. J Surg Oncol. 1993. 52:155–159.
5. Mirallie E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J. Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg. 1999. 23:970–974.
6. Shigematsu N, Takami H, Kubo A. Unique treatment policy for well-differentiated thyroid cancer in Japan: results of a questionnaire distributed to members of the Japanese Society of Thyroid Surgery and the International Association of Endocrine Surgeons. Endocr J. 2006. 53:829–839.
7. McConahey WM, Hay ID, Woolner LB, van Heerden JA, Taylor WF. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc. 1986. 61:978–996.
8. Ortiz S, Rodriguez JM, Soria T, Perez-Flores D, Pinero A, Moreno J, et al. Extrathyroid spread in papillary carcinoma of the thyroid: clinicopathological and prognostic study. Otolaryngol Head Neck Surg. 2001. 124:261–265.